| IPO Listing At | NSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹16.10 Cr |
| Reserved for Market Maker | ₹0.81 Cr |
| Net Issue Size | ₹16.10 Cr |
| Fresh Issue | ₹15.29 Cr |
| Face Value | โน10 Per Equity Share |
| Issue Price | โน43.00 per share |
| NSE Code | MEDISTEP |
| Registrar | Cameo Corporate Services Ltd. |
| Lead Managers | Novus Capital Advisors Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 6,000 shares ยท Multiples of 3,000 shares
Incorporated in June 2023, Medistep Healthcare Limited is a pharmaceutical company producing sanitary pads, energy powder, and various pharmaceutical, nutraceutical, intimate, and surgical products. They are committed to quality and seek to expand their product line as a public, non-government company.
The product includes the followings:-
As of December 30, 2024, Medistep reported annualized revenues of โน45.00 crore and a Profit After Tax (PAT) of โน4.08 crore.
As of December 28, 2024, the company has nine employees on payroll. Labour needs depend on daily-paid labourers, and none are on contract.
Competitive Strength:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility | 0.51 |
| 2 | Working Capital Requirements | 12.34 |
| 3 | General Corporate Purposes | 1.64 |
| 4 | Issue Expenses | 1.61 |
| Total | 16.10 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 22.99 | 14.96 | 14.66 |
| Total Income | 49.66 | 39.08 | 27.74 |
| Profit After Tax | 4.14 | 3.33 | 0.92 |
| EBITDA | 5.60 | 4.54 | 1.34 |
| NET Worth | 16.83 | 11.69 | 1.07 |
| Reserves and Surplus | 6.37 | 6.79 | |
| Total Borrowing | 0.64 | 0.33 | 0.53 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 29.06% |
| ROCE | 38.91% |
| RoNW | 29.06% |
| PAT Margin | 8.35% |
| EBITDA Margin | 11.27% |
| Price to Book Value | 2.67 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 3.96 | 2.92 |
| P/E (x) | 10.86 | 14.74 |
| Promoter Holding | 93.62% | 68.96% |
| Market Cap | โน61.10 Cr. | |